Protocol for a Phase IV Double-Blind Randomised Controlled Trial to Investigate the Effect of the 13-Valent Pneumococcal Conjugate Vaccine and the 23-Valent Pneumococcal Polysaccharide Vaccine on Pneumococcal Colonisation Using the Experimental Human Pneumococcal Challenge Model in Healthy Adults (PREVENTING PNEUMO 2).